Rapid test in the field using antibodies (akin to a COVID swab or pregnancy urine test) to detect a bioterrorism event, diagnose the specific toxin used, and then provide rapid injectable antibody treatment before the onset of symptoms.
Primary Application Area: Medical Devices & Materials
Technology Development Status: Concept
Technology Readiness Level: TRL 2
Organization Type: Early-stage Startup (Seed)
Market Keywords: point-of-care, sensor, therapeutic